Market Place
Sourcing Support
Moderna wins EU approval for combined flu, COVID shot
22 Apr 2026 //
REUTERS
Merck’s Welireg Triplet Fails Phase 3 in first-line kidney Cancer
22 Apr 2026 //
FIERCE PHARMA
US FDA approves Merck`s pill combo to treat HIV
22 Apr 2026 //
PRESS RELEASE
Trump orders FDA to fast-track reviews of psychedelic drugs
21 Apr 2026 //
FIERCE BIOTECH
Biogen inks $850M deal with TJ for China rights antibody
21 Apr 2026 //
FIERCE BIOTECH
Eli to buy Boston`s Kelonia for up to $7 Billion in Cancer Push
21 Apr 2026 //
BIOSOACE
Astra`s Tozorakimab Delivers Reduction in Lung Disease Flare-ups
21 Apr 2026 //
REUTERS
Boehringer launches AI centre for pharma research in London
21 Apr 2026 //
REUTERS
Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio Data
20 Apr 2026 //
PR NEWSWIRE
Rarecyte Expands Spatial Proteomics Portfolio With Orion Systems
20 Apr 2026 //
PHARMIWEB
Sapience Therapeutics Presents Phase 2 ST-316 Data at AACR 2026
20 Apr 2026 //
PR NEWSWIRE
Prelude Therapeutics Presents PRT13722 Data at 2026 AACR Meeting
20 Apr 2026 //
GLOBENEWSWIRE
Asahi Kasei Launches PhI Trial for Peptide in Autoimmune Diseases
20 Apr 2026 //
PHARMIWEB
Bicycle Pharma Updates Nuzefatide Pevedotin, EphA2 Pipeline
20 Apr 2026 //
PHARMIWEB
NRx Pharma Supports Initiative For Psychedelic Meds
20 Apr 2026 //
FIRSTWORD PHARMA
Novo`s Etavopivat Meets Both Endpoints in Sickle Cell Disease
20 Apr 2026 //
GLOBENEWSWIRE
Monte Rosa Unveils CCNE1-directed Molecular Glue Degrader
20 Apr 2026 //
GLOBENEWSWIRE
Lirum Therapeutics Presents Positive LX-101 Data at AACR 2026
20 Apr 2026 //
FIRSTWORD PHARMA
Immuneering`s AACR Data Backs Atebimetinib in Pancreatic Cancer
20 Apr 2026 //
GLOBENEWSWIRE
Greenwich LifeSciences Presents Open-Label Data at AACR Meeting
20 Apr 2026 //
GLOBENEWSWIRE
Genprex Shows Lung Cancer Gene Therapy Data at AACR 2026
20 Apr 2026 //
PR NEWSWIRE
Fapon Bio Showcases Core Tech Platforms At AACR 2026 Meeting
20 Apr 2026 //
PR NEWSWIRE
CytoDyn Shares Leronlimab Data for Metastatic TNBC Cancer
20 Apr 2026 //
GLOBENEWSWIRE
Calidi Presents In Situ T-Cell Engager Data at AACR 2026
20 Apr 2026 //
GLOBENEWSWIRE
BriaCell Shares Positive Ph3 QoL & Ph2 Data in 2026
20 Apr 2026 //
GLOBENEWSWIRE
BioCardia, PMDA Agree on CardiAMP Data for Ischemic Heart Failure
20 Apr 2026 //
GLOBENEWSWIRE
Alligator Bioscience`s Mitazalimab Data To Debut At AACR 2026
20 Apr 2026 //
PHARMIWEB
Abcellera To Present ABCL635 Phase 1 Clinical Data In Q1 2026
20 Apr 2026 //
PHARMIWEB
CPC Biotech Launches Versatile AseptiQuik G Connector
20 Apr 2026 //
PR NEWSWIRE
With global goals, Zai Lab offers China reality check
20 Apr 2026 //
FIERCE BIOTECH
Sanofi`s new COVID shot tops Moderna`s mNexspike in safety trial
20 Apr 2026 //
PRESS RELEASE
Nektar’s long-term Mid-Stage Alopecia Data fuel Phase 3 plans
20 Apr 2026 //
ENDPOINTS
Nektar Therapeutics Announces Proposed Public Offering
20 Apr 2026 //
FIRSTWORD PHARMA
GSK`s Blenrep bags approval in China
20 Apr 2026 //
PRESS RELEASE
FibroBiologics Compliant with All Nasdaq Listing Requirements
20 Apr 2026 //
FIRSTWORD PHARMA
Elisrasib Shows Promising Response Rates In Advanced Lung Cancer
19 Apr 2026 //
FIRSTWORD PHARMA
ASCO Expands Landmark Trial with First ADC Cohorts
19 Apr 2026 //
FIRSTWORD PHARMA
Zymeworks Unveils Preclinical Data on Novel RAS-Targeting ADCs
19 Apr 2026 //
FIRSTWORD PHARMA
Zealand Pharma Insiders Trade Shares, Securities
19 Apr 2026 //
GLOBENEWSWIRE
Yaqrit`s Phase 2a Data Boosts Consensus for YAQ007, YAQ006 in HE
19 Apr 2026 //
FIRSTWORD PHARMA
Xenon Unveils Azetukalner Phase 3 Results At 2026 AAN Meeting
19 Apr 2026 //
GLOBENEWSWIRE
Upstream Bio To Unveil Phase 2 Verekitug Data At ATS 2026
19 Apr 2026 //
FIRSTWORD PHARMA
SK Life Science Labs To Unveil Targeted Protein Degradation Data
19 Apr 2026 //
FIRSTWORD PHARMA
Revolution to Present Updated Ph 1 Clinical Data for Zoldonrasib
19 Apr 2026 //
FIRSTWORD PHARMA
Pyxis Shows Anti-Tumor Combo Data in HNSCC at AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Pheast Therapeutics Reveals PHST001 Phase 1A Data At AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
ORIC Pharma Highlights Rinzimetostat`s Prostate Cancer Potential
19 Apr 2026 //
FIRSTWORD PHARMA
Olema Oncology Unveils Palazestrant, OP-3136 Preclinical Data
19 Apr 2026 //
FIRSTWORD PHARMA
Odyssey Therapeutics Refiles for $100M IPO in Autoimmune Diseases
19 Apr 2026 //
FIRSTWORD PHARMA
KIMMTRAK Doubles 5-Year Survival in First-Line Uveal Melanoma
19 Apr 2026 //
GLOBENEWSWIRE
Immatics` TCR Achieves Remission in Children with Nephroblastoma
19 Apr 2026 //
FIRSTWORD PHARMA
Evaxion Shows AI-Immunology Platform Scalability In Glioblastoma
19 Apr 2026 //
FIRSTWORD PHARMA
Dana-Farber To Present 50+ Studies At AACR Annual Meeting 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Cogent Bio Presents Posters At AACR Annual Meeting 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Cardiff Oncology Unveils Onvansertib Data With Her2-Targeted ADC
19 Apr 2026 //
FIRSTWORD PHARMA
Cantargia Unveils AACR 2026 Presentation On Nadunolimab Study
19 Apr 2026 //
FIRSTWORD PHARMA
Boundless Bio Presents Kinesin Degrader Data at AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Biolojic Design Presents New Preclinical Data for BD200
19 Apr 2026 //
FIRSTWORD PHARMA
Zentalis Shares Azenosertib Data in TNBC at AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Asgard Therapeutics To Unveil AT-108, Gene Therapy Data At AACR
19 Apr 2026 //
FIRSTWORD PHARMA
